Collecting health data and samples from adults with suspected inflammatory muscle disease
Follows adults with suspected idiopathic inflammatory myopathy, gathering health information and body samples over time.
Key facts
- Who runs it
- University Hospital, Brest
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Adult Autoimmune Myopathies (MAIA)
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 20 May 2022
- Expected to end
- 20 May 2030
- Type of study
- Interventional
- Treatments tested
- description of adult autoimmune myopathies
- Record updated
- 25 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults whose doctors suspect an inflammatory muscle disease (idiopathic inflammatory myopathy). Clinical data and samples of blood, urine, stool and muscle will be collected over time.
- Age
- 18 Years and older
- Sex
- All sexes
- Disease stage
- Clinical suspicion of adult inflammatory myopathy
Main reasons for not taking part
- Pregnant or breastfeeding women
- People unable to give consent
- People who refuse to take part
- People under legal protection
- People without social security coverage
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Clinical suspicion of Adult Inflammatory Myopathy
- Social security affiliation
Who cannot take part
- Pregnant and lactating women
- Patients unable to consent
- Patients refusing to participate in the research
- Patients under legal protection
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study corresponds to a monocentric prospective cohort of adult patients presenting a suspicion of idiopathic inflammatory myopathy. It will allows the constitution of an organized collection of longitudinal clinical data as well as collection of biological samples, including blood sample, urine, stool and muscle specimen.
The group in the trial
- Adult Autoimmune MyopathiesOther group
It is a description Autoimmune Myopathie cohort
Treatment: description of adult autoimmune myopathies
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Adult Autoimmune Myopathies (MAIA): Clinical and Immunological Characterization, Constitution of a Patient Library
- Plain-language title
- Collecting health data and samples from adults with suspected inflammatory muscle diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 25 June 2026